ArticleMolecular diversity2025
Titania: an integrated tool for in silico molecular property prediction and NAM-based modeling.
Article in Molecular diversity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Advances in drug discovery and material design rely heavily on in silico analysis of extensive compound datasets and accurate assessment of their properties and activities through computational methods. Efficient and reliable prediction of molecular properties is crucial for rational compound design in the chemical industry. To address this need, we have developed predictive models for nine key properties, including the octanol/water partition coefficient, water solubility, experimental hydration free energy in water, vapor pressure, boiling point, cytotoxicity, mutagenicity, blood-brain barrier permeability, and bioconcentration factor. These models have demonstrated high predictive accuracy and have undergone thorough validation in accordance with OECD test guidelines. The models are seamlessly integrated into the Enalos Cloud Platform through Titania ( https://enaloscloud.novamechanics.com/EnalosWebApps/titania/ ), a comprehensive web-based application designed to democratize access to advanced computational tools. Titania features an intuitive, user-friendly interface, allowing researchers, regardless of computational expertise, to easily employ models for property prediction of novel compounds. The platform enables informed decision-making and supports innovation in drug discovery and material design. We aspire for this tool to become a valuable resource for the scientific community, enhancing both the efficiency and accuracy of property and toxicity predictions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.